Bauer J, Garbe C
Ozempic Use Linked to Vision Loss and NAION Study Highlight: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide In July 2024, researchers at Mass Eye and Ear found a potential link between the use of semaglutide and an increased risk of developing NAOIN, a rare but serious condition
This approach ensures comprehensive coverage of the existing evidence while following a rigorous selection process, thereby providing a stronger foundation for analyzing the health benefits of IF
Headline numbers come from different populations, durations, and estimand definitions the table is for orientation, not direct conclusion
Segulatide is a common misspelling of semaglutide
Lillys warning about gastrointestinal adverse reactions, sometimes severe is likewise inadequate and vague: warning of an episode of severe vomiting does not, itself, warn of the risk of weeks of vomiting due to stomach paralysis, which may lead to hospitalization or death, and which may not abate after stopping the drug